aTyr Pharma | LIFE - Capital Ordinário





Capital Ordinário Alterar Data
Alterity Therapeutics Limited AUD 213.97M 144.39K 2023-06
Ardelyx USD 238.02M 1.13M 2024-12
aTyr Pharma USD 97.99M 97.9M 2025-09
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cipla INR 807.77M 807.43M 2025-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 93.54M 3.99M 2025-06
CSL USD 482.13M 93.87M 2025-12
Curis USD 59K 934K 2023-09
Galapagos EUR 65.9M 0 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Grifols EUR 679.73M 0 2025-09
Novartis USD 1.94B 23.4M 2025-06
Roche Holding CHF 795.62M 699.54K 2025-12
United Therapeutics USD 43.64M 740K 2025-12
Xoma USD 87K 1000 2024-06